US EditionPublished • loading... • Updated
Early effective therapy is the Answer. If not what’s the question
Summary by Multiple Sclerosis Research Blog
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Early effective therapy is the Answer. If not what’s the question
Tweet Alroughani R, Ahmed SF. Treatment outcomes of high-efficacy disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: A longitudinal observational study. Mult Scler Relat Disord. 2026 Jan 19;108:107024. doi: 10.1016/j.msard.2026.107024. Epub ahead of print. Background: The evolution of high-efficacy disease-modifying therapies (HE-DMTs) has significantly shifted the management of relapsing-remitting multiple scle…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
